SCOTTSDALE, Ariz., May 1, 2025 – SimonMed Imaging (“SimonMed”), one of the largest outpatient medical imaging providers in the U.S., today announced the launch of DEXA + TBS (Trabecular Bone Score), a next-generation bone health screening that combines bone density and bone quality analysis—setting a new standard of care in osteoporosis detection and fracture prevention.
The announcement comes ahead of National Osteoporosis Awareness and Prevention Month in May. Osteoporosis, often called a “silent disease,” weakens bones without warning—until a fracture happens. Each year, osteoporosis causes an estimated 2 million fractures in the U.S., yet nearly 80% of older adults who suffer fractures are never tested or treated, according to the Bone Health and Osteoporosis Foundation. Early detection is critical to preventing the serious, life-altering impacts of untreated bone loss.
Developed in partnership with Medimaps Group, DEXA + TBS integrates FDA-approved software into standard DEXA scans to measure both bone mineral density (BMD) and trabecular bone score (TBS), which evaluates bone microarchitecture. This dual analysis allows clinicians to identify up to 30% more patients at high risk of fracture, even when bone density appears normal.
“Osteoporosis is often diagnosed too late—after a fracture has already impacted quality of life,” said Dr. John Simon, CEO and Founder of SimonMed Imaging. “With DEXA + TBS, we’re giving patients and providers a more complete picture of bone health so they can make proactive decisions earlier, to prevent and treat the disease.”
Osteoporosis affects millions—impacting 1 in 2 women and 1 in 4 men over age 50 with a lifetime risk of fracture. Early detection is critical.
“Our partnership with SimonMed is about shifting from reactive to proactive care,” said Univ.-Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps Group. “By expanding access to advanced diagnostics like TBS, we enable smarter, earlier decisions that prevent fractures and improve outcomes.”
DEXA + TBS is now available at over 80 SimonMed locations equipped with DEXA technology, furthering the company’s mission to make cutting-edge diagnostics both affordable and accessible.
SimonMed continues to lead in AI-powered imaging across multiple specialties— including breast cancer, brain health, and now, bone health.
